The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index; none of the 16 sources its claims cite is checked for support yet.
Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.
Open accessAbstract
Cytokines are recognized as critical early mediators of organ injury. We attempted to determine whether or not severe hepatic ischemia/reperfusion injury results in tumor necrosis factor-alpha (TNF-alpha) release with subsequent local and systemic tissue injury. After 90 min of lobar hepatic ischemia, TNF was measurable during the reperfusion period in the plasma of all 14 experimental animals, with levels peaking between 9 and 352 pg/ml. Endotoxin was undetectable in the plasma of these animals. Pulmonary injury, as evidenced by a neutrophilic infiltrate, edema and intra-alveolar hemorrhage developed after hepatic reperfusion. The neutrophilic infiltrate was quantitated using a myeloperoxidase (MPO) assay; this demonstrated a significant increase in MPO after only 1 h of reperfusion. Anti-TNF antiserum pretreatment significantly reduced the pulmonary MPO after hepatic reperfusion. After a 12-h reperfusion period, there was histologic evidence of intra-alveolar hemorrhage and pulmonary edema. Morphometric assessment showed that pretreatment with anti-TNF antiserum was able to completely inhibit the development of pulmonary edema. Liver injury was quantitated by measuring serum glutamic pyruvic transaminase which showed peaks at 3 and 24 h. Anti-TNF antiserum pretreatment was able to significantly reduce both of these peak elevations. These data show that hepatic ischemia/reperfusion results in TNF production, and that this TNF is intimately associated with pulmonary and hepatic injury.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In a rat model of 90-minute lobar hepatic ischemia/reperfusion, TNF became measurable in plasma in all 14 experimental animals and was associated with subsequent pulmonary and hepatic injury. Pretreatment with anti-TNF antiserum reduced pulmonary neutrophil sequestration, abolished pulmonary edema, and lowered serum SGPT elevations after reperfusion.
Key findings
- After hepatic ischemia/reperfusion, TNF was measurable in plasma of all 14 experimental animals, with a mean peak level of 69.4±30.3 pg/ml and a range of 9–352 pg/ml; TNF was undetectable in sham-operated controls, and endotoxin was undetectable (<5 pg/ml).
- Pulmonary neutrophil sequestration, measured by MPO, peaked after 1 h of reperfusion at 0.653±0.089 U versus 0.213±0.034 U in sham animals (P<0.005). Anti-TNF antiserum reduced MPO to 0.458±0.057 U compared with 0.701±0.040 U in control-serum animals (P<0.005), though it did not return values to sham baseline.
- After 12 h of reperfusion, control-serum animals had 20±4 flooded alveoli/high-power field, whereas anti-TNF antiserum-treated animals had 0±0 (P<0.05 by Wilcoxon rank-sum test).
- Serum SGPT peaked at 3 and 24 h after reperfusion; anti-TNF antiserum significantly reduced both peak elevations (P<0.05 at 3 h and P<0.005 at 24 h versus untreated and control-serum groups). Twenty-four-hour survival was 67% in untreated animals, 92% with anti-TNF antiserum, and 60% with control serum, but the differences were not statistically significant.
Methods
- Adult male pathogen-free Sprague-Dawley rats (200–300 g) underwent 90 min of lobar hepatic ischemia using a Heifitz clip, with sham-operated controls treated identically except for vascular occlusion.
- Plasma TNF activity was measured with a WEHI 164 subclone 13 bioassay; positive samples were confirmed by neutralization with polyclonal rabbit anti-murine TNF antiserum. Endotoxin was measured by a perchloric acid-modified chromogenic limulus assay.
- Organ injury was assessed by pulmonary MPO assay, blinded histologic morphometry of edema-filled alveoli, and serum SGPT. Anti-TNF effects were tested by pretreating rats with polyclonal rabbit anti-murine TNF antiserum versus control rabbit serum. Statistical comparisons used Student Newman-Keuls or Wilcoxon rank-sum tests when data were not normally distributed.
Limitations
- The paper states that 24-h survival differences were not statistically significant, most likely because of relatively small group sizes.
- The paper states that further studies are needed to document the degree to which the observed pulmonary pathology is neutrophil dependent.
- The paper states that the mechanism of TNF induction after hepatic ischemia/reperfusion is not completely clear; the text infers Kupffer cell production/leakage but does not directly establish the cellular source.
- Evident from the text: anti-TNF antiserum did not prevent the transient hypotension after revascularization, so the protective effects observed were not attributable to hemodynamic stabilization.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
35 Own result · 14 Not checked yet · 12 Own interpretation · 4 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After 90 min of lobar hepatic ischemia, TNF was measurable during the reperfusion period in the plasma of all 14 experimental animals, with levels peaking between 9 and 352 pg/ml.”
- Also stated in: § Results · plain
“TNF was measurable in the plasma of all 14 experimental animals”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
plainn = 14- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endotoxin was undetectable in the plasma of these animals.”
- Also stated in: § Results · plain
“In addition, endotoxin was unde- tectable (< 5 pg/ml).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
plainn = 14- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TNF was un- detectable at any time point in the three sham-operated con- trol animals”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The neutrophilic infiltrate was quantitated using a myeloperoxidase (MPO) assay; this demonstrated a significant increase in MPO after only 1 h of reperfusion.”
- Also stated in: § Results · plain
“1 h postrevascularization, mean pulmonary MPO was 0.653±0.089U as compared with 0.213±0.034U for sham-operated animals (P < 0.005; Fig. 3.).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
boosteddirectn = 5 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pulmonary injury, as evidenced by a neutrophilic infiltrate, edema and intra-alveolar hemorrhage developed after hepatic reperfusion.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and that a picture of pulmonary neutrophil sequestration and hemorrhagic edema develops.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“of 12 animals treated with anti-TNF antiserum before the induction of hepatic ischemia, 11 animals survived for 24 h, giving a 24-h survival of 92%.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
plainn = 12- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For animals undergoing hepatic ischemia and reperfusion alone, the mean minimum systolic blood was significantly different from sham-operated an- imals (P < 0.005).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of 24 animals undergoing 90 min of lobar hepatic ischemia and 24 h of reperfusion, eight animals ex- pired before 24 h, resulting in a 24-h survival of 67%.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
plainn = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This was not the result of protection from a hypotensive effect, since the anti-TNF and control serum groups showed the same degree of transient hypotension after clamp release.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 17
- The quote only partly states this claim. 3
- Probably not a substantial claim. 7
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean peak TNF level was 69.4±30.3pg/ml with a range of 9-352 pg/ml.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
plainn = 14- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, anti-TNF treatment blunted the increase in pulmonary MPO but did not reduce the MPO level to that observed in sham-operated controls.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
plaindirectn = 10- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MPO levels were maximal after 1 h of reperfusion and gradually decreased over the next 11 h.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
plaincorrelationaln = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“24 h survival in animals treated with control serum was similar to that seen in the untreated experimental group with 6 of 10 animals surviving for 24 h.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
plainn = 10- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the anti-TNF-treated rats illustrate essentially normal histology.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Anti-TNF antiserum pretreatment was able to significantly reduce both of these peak elevations.”
- Also stated in: § Results · plain
“SGPT levels were significantly decreased both 3 and 24 h postrevascularization in the animals treated with anti-TNF antiserum as compared to untreated experimental animals and animals treated with control serum (P < 0.05 after 3 h of reperfusion and”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
plaindirectn = 6 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Statistical significance was not achieved between any of the groups, most likely due to the relatively small numbers in the groups.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
hedgedn = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After 3 h of hepatic reperfusion, there was a significant decrease in SGPT in animals pretreated with anti-TNF antiserum as compared with both the untreated ex- perimental animals and the control serum-treated animals.”
- Also stated in: § Discussion · hedged
“Animals treated with anti-TNF antiserum showed a significant reduction in a hepatocyte-specific enzyme (SGPT) after hepatic ischemia/reperfusion in comparison to controls treated with control serum”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- Also stated in: § Discussion · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Anti-TNF antiserum pretreatment significantly reduced the pulmonary MPO after hepatic reperfusion.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the operated rats show intra-alveolar hemorrhage and some edema fluid.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Recent clinical data have shown that impaired hepatic function greatly influences severity and impedes reso- lution of ARDS (4).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Introduction
What the sources say
- Not checked yetcites [4]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Since the pulmonary circulation represents the first vascu- lar bed into which these cytokines are delivered, the pulmonary parenchyma would be likely to manifest the toxic effects of these cytokines.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Introduction
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The pulmonary circulation is the first vascular bed into which cytokines from injured liver are delivered.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The lower limit of endotoxin detection in this assay is 5 pg/ml.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The TNF release also did not appear directly related to the hypotensive effect produced by the I/R process, since anti-TNF antiserum treatment blocked the observed pathology, but did not alter the hypotension following clamp release.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“primary nonfunction of the graft after liver transplantation is also associated with the rapid development ofpulmonary insufficiency (5).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Introduction
What the sources say
- Not checked yetcites [5]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The pulmonary pathology appears to be a consequence of TNF, since pretreatment with neutralizing anti-TNF anti- serum blunted the neutrophilic infiltrate (as measured by MPO) and completely abolished both the diffuse edema and patchy hemorrhage.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Slides were examined in a blinded manner.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Myeloperoxidase (MPO) assay. Pulmonary neutrophil sequestra- tion was quantitated with the MPO assay (I14).
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Previous in vitro studies have docu- mented the ability of Kupffer cells to produce TNF (28).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
What the sources say
- Not checked yetcites [28]
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“This antiserum neutralizes both natural and recombinant TNF, cross-reacts with rat TNF and has no cross-reactivity with interleukin 1.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
What the sources say
- Not checked yetcites 1 1, 12
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Previous studies have documented a deleterious effect of TNF on the hepatocyte where infused rTNF results in focal hepatic necrosis, as does LPS infusion, and the latter finding could be blocked with anti-TNF antiserum (13).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
What the sources say
- Not checked yetcites [13]
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“However, our model was specifically chosen to avoid such vascular con- gestion, involving only lobar vascular occlusion with unim- peded portal flow to the right lobe.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The three caudal lobes retain an intact portal inflow and venous out- flow, preventing intestinal venous congestion and possible leakage of bacteria or bacterial products into the circulation.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“These data confirm our earlier study which used an intravenous ra- dioactive tracer to document protein leakage into the lungs (9).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
What the sources say
- Not checked yetcites [9]
plainn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“By utilizing a rat model of lobar, rather than total, hepatic ischemia, a severe ischemic insult was produced without in- ducing mesenteric venous hypertension (8).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
What the sources say
- Not checked yetcites [8]
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and that TNF has both local deleterious effects on the hepatocyte and extensive damaging effects on pulmonary integrity.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
TNF is produced primarily by cells of the monocyte/macrophage lineage.
“TNF is produced primarily by cells of the monocyte/macrophage lineage”
The paper relies on this without support.
The liver Kupffer cell mass is the largest fixed macrophage population in the body.
“the liver Kupffer cell mass is the largest fixed macrophage population in the body.”
The paper relies on this without support.
The pulmonary circulation is the first vascular bed into which cytokines from injured liver are delivered.
“the pulmonary circulation represents the first vascu- lar bed into which these cytokines are delivered”
The paper relies on this without support.
The anti-TNF antiserum used in these experiments neutralizes TNF in vivo and does not have other relevant biological activities that could account for the observed protection.
“pretreatment with neutralizing anti-TNF anti- serum blunted the neutrophilic infiltrate”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reperfusion of ischemic tissues stimulates cytokine overproduction (e.g., TNF, IL-1, HMGB1), which contributes to the pathogenesis of resulting tissue damage (42)(43)(44).”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
“Previous studies have documented a deleterious effect of TNF on the hepatocyte where infused rTNF results in focal hepatic necrosis, as does LPS infusion, and the latter finding could be blocked with anti-TNF antiserum (13).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > References
“13. Obayashi, T. 1984. Addition of perchloric acid to blood sam- ples for colorimetric limulus, test using chromogenic substrate: com- parison with conventional procedures and clinical applications. J. Lab. Clin. Med. 104:321-330.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
“renal allograft rejection (24)”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > References
“24. Scuderi, P., K. E. Sterling, K. S. Lam, P. R. Finley, K. J. Ryan, C. G. Ray, E. Peterson, D. J. Slyman, and S. E. Salmon. 1986. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet. 1:1364-1365.”
Citations
Cites
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,256
Waage, A., Halstensen, A. I., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,085
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W. C., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,059
Gamble, J. R., Harlan, J. M., Klebanoff, S. J., & Vadas, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8667 · Cited by 1,031
Shalaby, M. R., Aggarwal, B. B., Rinderknecht, E., Svedersky, L. P., Finkle, B. S., & Palladino, M. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.2069 · Cited by 916
Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria
Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., VASSALLI, P., Hommel, M., & Lambert, P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202404 · Cited by 839
Stimulation of neutrophils by tumor necrosis factor.
Klebanoff, S. J., Vadas, M. A., Harlan, J. M., Sparks, L., Gamble, J. R., Agosti, J. M., & Waltersdorph, A. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4220 · Cited by 832
Research works printed but not linked: 2
- Glantz, S. A. 1987. Primer of Biostatistics. 2nd edition.
- Bevilacqua, M. P., J. S. Pober, G. R. Majeau, W. Fiers, R. S. Cotran, and M. A. Gimbrone. 1986. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endo- thelium. Proc. Natl. Acad. Sci. USA. 83:4533-4537.
Cited by
Sorted by citations
Items 301–400 of 821
Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway
Jessup, J. M., Samara, R. N., Battle, P., et al. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-7705-z · Cited by 48
“These ROS then stimulate Kupffer cells, hepatic sinusoidal lining cells hepatocytes as well as leucocytes to release proinflammatory cytokines that sequester inflammatory cells [20, 30] that then release more RNOS as well as proteases [31].”
BackgroundKe, B., Shen, X., Lassman, C., et al. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00147.x · Cited by 48
Mahmoud, M. F., Shazly, S. M. E., & Barakat, W. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0729-z · Cited by 47
“The inhibition of TNF-α production or its neutralization with antiTNF-α antibodies decreases the number of neutrophils infiltrating the liver and reduces liver I/R injury (Colletti et al. 1990; Yang et al. 2004).”
RetractedMatuschak, G. M., HENRY, K. A., Johanns, C. A., & Lechner, A. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.2003020 · Cited by 47
“Thus, Colletti and coworkers ( 16 , 18) and McCurry and colleagues (17) reported increased export of TNF-a, IL-6, and CXC chemokines into hepatic venous blood after 90 min of ischemia and reperfusion injury of the liver over 24 h, coincident with increases in lung microvascular permeability and intrapulmonary accumula…”
BackgroundResultFarges, O., Morris, P. J., & Dallman, M. J. (1995) · Hepatology · doi:10.1002/hep.1840210326 · Cited by 47
Choi, E. K., & Lim, D. G. (2022) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2022.00017 · Cited by 48
“Although various cells in the liver release TNF-α, its production by Kupffer cells is the most prominent [38].”
TRAF1 is a key mediator for hepatic ischemia/reperfusion injury
Zhang, X., Zhang, R., Zhang, R., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.411 · Cited by 46
“Hepatic I/R results in TNF-α production by immune cells, which is correlated with the severity of liver injury.(30) In addition, hepatocytes have been shown to exhibit higher TNFR expression levels in acute and chronic inflammatory liver diseases.”
BackgroundTanaka, Y., Chen, C., Maher, J. M., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000226243.69023.54 · Cited by 46
“Partial hepatic IR model induces a severe ischemic insult to the liver without inducing mesenteric venous hypertension and subsequent bacterial translocation into the venous portal blood (30).”
BackgroundMartínez-Mier, G., Toledo-Pereyra, L. H., McDuffie, J. E., Warner, R. L., & Ward, P. A. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00360-4 · Cited by 45
Lead enhances lipopolysaccharide and tumor necrosis factor liver injury.
Honchel, R., Marsano, L. S., Cohen, D. A., Shedlofsky, S. I., & McClain, C. J. (1991) · PubMed · Cited by 46
Brock, R. W., Lawlor, K. D., Harris, K. A., et al. (1999) · Hepatology · doi:10.1002/hep.510300132 · Cited by 46
Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFα
Lang, C. H., Nystrom, G. J., & Frost, R. A. (2001) · Growth Hormone & IGF Research · doi:10.1054/ghir.2001.0233 · Cited by 45
LUNG-LIVER INTERACTIONS IN SEPSIS AND MULTIPLE ORGAN FAILURE SYNDROME
Matuschak, G. M. (1996) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70300-2 · Cited by 43
Role of leukotrienes on hepatic ischemia/reperfusion injury in rats
Takamatsu, Y., Shimada, K., Chijiiwa, K., et al. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2003.07.004 · Cited by 46
Urata, K., Nguyen, B., Brault, A., et al. (1998) · Hepatology · doi:10.1002/hep.510280211 · Cited by 46
Funaki, H., Shimizu, K., Harada, S.-I., et al. (2002) · Transplantation · doi:10.1097/00007890-200208270-00021 · Cited by 46
Kuzumoto, Y., Sho, M., Ikeda, N., Hamada, K., Mizuno, T., Akashi, S., Tsurui, Y., Kashizuka, H., Nomi, T., Kubo, A., et al. (2005) · Hepatology · doi:10.1002/hep.20827 · Cited by 46
“size by selective stimulation of prostaglandin EP(3)receptors in the reper-”
BackgroundJessé, C. R., Bortolatto, C. F., Wilhelm, E. A., et al. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2818 · Cited by 45
“Furthermore, PPAR-g agonists have been reported to reduce organ injury caused by ischemia/ reperfusion (Shimazu et al., 2005) and attenuate drug-induced toxicity (Colletti et al., 1990).”
BackgroundKupffer cell activation after no-flow ischemia versus hemorrhagic shock
Jaeschke, H., & Farhood, A. I. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00867-5 · Cited by 45
Inactivation of the small GTPase Rac1 protects the liver from ischemia/reperfusion injury in the rat
Harada, N., Iimuro, Y., Nitta, T., Yoshida, M., Uchinami, H., Nishio, T., Hatano, E., Yamamoto, N., Yamamoto, Y., & Yamaoka, Y. (2003) · Surgery · doi:10.1067/s0039-6060(03)00256-3 · Cited by 45
Kuboki, S., Sakai, N., Clarke, C. N., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.016 · Cited by 45
Kojima, Y., Suzuki, S., Tsuchiya, Y., et al. (2003) · Transplant International · doi:10.1111/j.1432-2277.2003.tb00293.x · Cited by 45
Caspase inhibition protects from liver injury following ischemia and reperfusion in rats
Cursio, R., Gugenheim, J., Ricci, J., et al. (2000) · Transplant International · doi:10.1007/s001470050405 · Cited by 45
The Central Role of Sinusoidal Endothelial Cells in Hepatic Hypoxia–Reoxygenation Injury in the Rat
Samarasinghe, D., & Farrell, G. C. (1996) · Hepatology · doi:10.1002/hep.510240541 · Cited by 44
Turnbull, A. V., Pitossi, F. J., Lebrun, J. J., Lee, S., Meltzer, J. C., Nance, D. M., del Rey, A., Besedovsky, H. O., & RIVIER, C. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03262.1997 · Cited by 52
Kireev, R. A., Cuesta‐Sancho, S., Ibarrola, C., Bela, T., González, E. M., Vara, E., & Tresguerres, J. A. F. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.04.060 · Cited by 44
Interleukin-1 in Ischemia-Reperfusion Acute Lung Injury
Chang, D., Hsu, K., Ding, Y. L., & Chiang, C. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.9702095 · Cited by 45
Whiting, J. F., Green, R. M., Rosenblüth, A., & Gollan, J. L. (1995) · Hepatology · doi:10.1002/hep.1840220437 · Cited by 44
Sakr, M. F., McClain, C. J., Gavaler, J. S., et al. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80209-0 · Cited by 44
Novel Approaches to Preventing Ischemia-Reperfusion Injury During Liver Transplantation
Akhtar, M. Z., Henderson, T., Sutherland, A., Vogel, T., & Friend, P. J. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.04.004 · Cited by 43
Rao, J., Qian, X., Wang, P., Pu, L., Zhai, Y., Wang, X., Zhang, F., & Lü, L. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.04.008 · Cited by 43
HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat
Liu, A., Dirsch, O., Fang, H., Sun, J., Jin, H., Dong, W., & Dahmen, U. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0802-6 · Cited by 44
“TNF-a levels are increased during liver I/R injury, and its neutralization reduced the liver injury and mortality in a rat model of liver I/R (Colletti et al. 1990).”
BackgroundKojima, Y., Suzuki, S., Tsuchiya, Y., et al. (2003) · PubMed · doi:10.1007/s00147-002-0536-4 · Cited by 43
“The enhanced TNF-a production may play a significant role in a sequence of events causing severe liver injury by polymorphonuclear neutrophils (PMNs) [ 4 , 8, 27, 34].”
BackgroundInfluentialBen‐Ari, Z., Hochhauser, E., Burstein, I., et al. (2002) · Transplantation · doi:10.1097/00007890-200206270-00004 · Cited by 43
Liver dysfunction elicited by gut ischemia–reperfusion
Horie, Y., & Ishii, H. (2001) · Pathophysiology · doi:10.1016/s0928-4680(01)00063-3 · Cited by 43
“[59] L.”
BackgroundIschemic preconditioning: tolerance to hepatic ischemia-reperfusion injury.
Serafín, A., Fernández-Zabalegui, L., Prats, N., et al. (2004) · PubMed · doi:10.14670/hh-19.281 · Cited by 43
“…mediators, including endothelin (ET) and tumor necrosis factor-alpha (TNF), and the neutrophil accumulation can further enhance the injury (Schmid-Schonbein, 1987; Colletti et al., 1990b; Jaeschke et al., 1990; Goto et al., 1994; Peralta et al., 1996, 2000, 2001a; Sawaya et al., 1999).”
Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function
Fukata, J., Imura, H., & Nakao, K. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347705 · Cited by 43
Yamada, S., Iida, T., Tabata, T., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.9604 · Cited by 43
Okada, K., Fujita, T., Minamoto, K., Liao, H., Naka, Y., & Pinsky, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002682200 · Cited by 42
Muriel, P., & Deheza, R. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00837.x · Cited by 42
Ke, B., Shen, X., Tsuchihashi, S.-I., et al. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.181 · Cited by 42
Yeh, C., Lin, Y., Wu, Y., et al. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000155385.41479.b3 · Cited by 42
Motomura, K., Ohata, M., Satre, M. A., & Tsukamoto, H. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.3.e420 · Cited by 42
“TNF-a is considered the central mediator in liver damage induced by a variety of hepatotoxic conditions, because administration of antibodies against TNF-a (7, 16) or soluble receptor for this cytokine (8) offers hepatoprotective effects under these conditions.”
BackgroundCholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse
Georgiev, P., Navarini, A. A., Eloranta, J. J., et al. (2006) · Gut · doi:10.1136/gut.2006.097170 · Cited by 42
Regulation of Liver Inflammatory Injury by Signal Transducer and Activator of Transcription-6
Kato, A., Yoshidome, H., Edwards, M. J., & Lentsch, A. B. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64540-3 · Cited by 40
Yao, Y.-M., Bahrami, S., Redl, H. R., & Schlag, G. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00020 · Cited by 41
Tanaka, Y., Chen, C., Maher, J. M., & Klaassen, C. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm261 · Cited by 41
“During the initial phase of hepatic IR injury, Kupffer cells are activated and release reactive oxygen species and proinflammatory cytokines, such as tumor necrosis factoralpha, interleukin 1b (IL-1b), and IL-6 (Colletti et al., 1990; Wanner et al., 1996).”
BackgroundInfluentialKish, D. D., Volokh, N., Baldwin, W. M., & Fairchild, R. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002337 · Cited by 41
Helicobacter pylori and gastric diseases.
Goto, H. (2003) · PubMed · doi:10.18999/nagjms.66.3-4.77 · Cited by 41
Neutrophil Depletion and Chemokine Response after Liver Ischemia and Reperfusion
Martínez-Mier, G., Toledo-Pereyra, L. H., McDuffie, J. E., Warner, R. L., & Ward, P. A. (2001) · Journal of Investigative Surgery · doi:10.1080/08941930152024228 · Cited by 41
Colletti, L. M., Green, M. E., Burdick, M. D., & Strieter, R. M. (2000) · Hepatology · doi:10.1002/hep.510310225 · Cited by 41
Self-citationJin, X., Wang, L., Wu, H., et al. (2007) · PubMed · Cited by 41
Liver-Lung Interactions in Critical Illness
Matuschak, G. M. (1995) · Update in intensive care and emergency medicine · doi:10.1007/978-3-642-79715-6_7 · Cited by 38
Amelioration of lung reperfusion injury by L- and E- selectin blockade
Demertzis, S., Langer, F., Graeter, T. P., et al. (1999) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(99)00206-7 · Cited by 41
The effects of FR167653 in extended liver resection with ischemia in dogs
Kobayashi, J., Takeyoshi, I., Ohwada, S., Iwanami, K., Matsumoto, K., Muramoto, M., & Morishita, Y. (1998) · Hepatology · doi:10.1002/hep.510280225 · Cited by 41
Pioglitazone Attenuates Ischemia/Reperfusion–Induced Liver Injury in Rats
Somi, M. H., Hajipour, B., Asl, N. A., et al. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.09.075 · Cited by 40
“There are 3 PPAR class compounds: trolitazone, rosiglitazone, and pioglitazone.(3) Although trogliazone administration produced severe liver toxicity in case eports, the new thiazolidinediones seem to be safe.”
BackgroundKato, A., Okaya, T., & Lentsch, A. B. (2003) · Hepatology · doi:10.1053/jhep.2003.50075 · Cited by 40
Effects of tacrolimus on ischemia-reperfusion injury
Peter, S. D. S., Moss, A. A., & Mulligan, D. C. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50020 · Cited by 40
Zaki, A. M., El-Tanbouly, D. M., Abdelsalam, R. M., & Zaki, H. F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.004 · Cited by 40
Reperfusion injury after warm ischemia or cold storage of the liver: Role of apoptotic cell death
Jaeschke, H. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)03464-4 · Cited by 40
DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR GENE
Rosen, H. R., Lentz, J. J., Rose, S. L., et al. (1999) · Transplantation · doi:10.1097/00007890-199912270-00014 · Cited by 40
Yonezawa, K., Yamamoto, Y., Yamamoto, H., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00191-x · Cited by 40
Polat, C., Tokyol, Ç., Kahraman, A., et al. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.03.007 · Cited by 39
Pulitanò, C., Aldrighetti, L. A., Arru, M., et al. (2007) · HPB · doi:10.1080/13651820701216984 · Cited by 39
Compartmentalization of the inflammatory response in sepsis and SIRS
Cavaillon, J., & Annane, D. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120030301 · Cited by 248
Zhang, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i28.4423 · Cited by 39
“So that the development of intestinal congestion and leakage of bacteria or bacterial products into the circulation can be avoided[6, 7 ].”
BackgroundInfluentialEffect of ethanol on tumor necrosis factor signaling during liver regeneration
Diehl, A. M. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00057-0 · Cited by 40
Sugawara, Y., Kubota, K., Ogura, T., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80125-6 · Cited by 39
Local and systemic effects of macrophage cytokines in intestinal inflammation
MURCH, S. H. (1998) · Nutrition · doi:10.1016/s0899-9007(98)00083-5 · Cited by 37
Development of a Porcine Model of Post-Hepatectomy Liver Failure
Arkadopoulos, N. F., Defterevos, G., Nastos, C., Papalois, A. E., Kalimeris, K. A., Papoutsidakis, N., Καμπούρογλου, Γ., Kypriotis, D., Pafiti, A., Kostopanagiotou, G. G., et al. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.06.006 · Cited by 37
Vinpocetine protects liver against ischemia–reperfusion injury
Zaki, H. F., & Abdelsalam, R. M. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0097 · Cited by 38
“Ischemia was induced in rats by clamping the common hepatic artery and portal vein, according to the method described by Colletti et al. (1990), for 30 min followed by 30 min of reperfusion.”
MethodEffect of leptin on renal ischemia-reperfusion damage in rats
Erkasap, S., Erkasap, N., Köken, T., Kahraman, A., Uzuner, K., Yazıhan, N., & Ateş, E. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03168443 · Cited by 38
Lawlor, D. K., Brock, R. W., Harris, K. A., & Potter, R. F. (1999) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(99)70081-9 · Cited by 37
Gene deletion of NF-κB p50 does not alter the hepatic inflammatory response to ischemia/reperfusion
Kato, A., Edwards, M. J., & Lentsch, A. B. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00068-5 · Cited by 38
Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol
Shiratori, Y., Takada, H., Hikiba, Y., Nakata, R., Okano, K., Komatsu, Y., Niwa, Y., Matsumura, M., Shiina, S., Omata, M., et al. (1993) · Hepatology · doi:10.1002/hep.1840180629 · Cited by 40
In vitro tumor necrosis factor cytotoxicity in HEP G2 liver cells
Hill, D. B., Schmidt, J., Shedlofsky, S. I., Cohen, D. A., & McClain, C. J. (1995) · Hepatology · doi:10.1002/hep.1840210434 · Cited by 38
Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury
Moussavian, M. R., Scheuer, C., Schmidt, M., et al. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0668-4 · Cited by 37
“[37] and others could demonstrate that inhibition of TNF-alpha is effective to significantly reduce I/R injury, indicating a deleterious role of this pro-inflammatory cytokine on postischemic organ integrity.”
BackgroundSuzuki, S., Nakamura, S., Sakaguchi, T., et al. (1997) · Transplantation · doi:10.1097/00007890-199709270-00006 · Cited by 37
Scoazec, J., Durand, F., Degott, C., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90234-8 · Cited by 37
Kareem, B. N., Karlsen, F., Holm, R., Hennig, E. M., Suo, Z., Emilsen, E., Hellesylt, E., & Nesland, J. M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199712)183:4 · Cited by 4
The Many Facets of Reperfusion Injury
Lemasters, J. J., & Thurman, R. G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90237-6 · Cited by 36
Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats
Zhang, T., Shu, H., Chang, L., et al. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.06.017 · Cited by 36
Hepatocyte Protection by a Protease Inhibitor Against Ischemia/reperfusion Injury of Human Liver1
Kim, Y.-I., Hwang, Y.-J., Song, K., et al. (2002) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(01)01118-8 · Cited by 36
Yanagida, H., Kaibori, M., Yoshida, H., Habara, K., Yamada, M., Kamiyama, Y., & Okumura, T. (2006) · Shock · doi:10.1097/01.shk.0000223130.87382.73 · Cited by 36
“(22), ischemia was induced in the median and left lateral lobes of the liver (70% of liver mass) by clamping the structures (hepatic artery, portal vein, and bile duct) with a microvascular clamp.”
BackgroundAlanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats
Jia, C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i9.1373 · Cited by 36
Immunotoxicology of host-response-mediated experimental liver injury
Tiegs, G. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80256-4 · Cited by 36
Kageyama, S., Kadono, K., Hirao, H., et al. (2020) · Transplantation · doi:10.1097/tp.0000000000003488 · Cited by 35
Kawashima, Y., Takeyoshi, I., Otani, Y., et al. (2001) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(01)00243-1 · Cited by 35
Caspase inhibition protects from liver injury following ischemia and reperfusion in rats
Cursio, R., Gugenheim, J., Ricci, J., et al. (2000) · Transplant International · doi:10.1111/j.1432-2277.2000.tb02108.x · Cited by 35
“suggested that it represents a transient response to acute ischemia [23]; it plays a role in ischemia/reperfusion injury and is triggered by mild hypoxia, reactive oxygen intermediates, and cytokines produced by Kupffer cells and neutrophils [3, 5, 6].”
BackgroundExpression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys
Padanilam, B. J., Lewington, A. J. P., & Hammerman, M. R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00197.x · Cited by 35
“Pretreatment of rats rendered ischemic with anti-TNF antiserum attenuates the injur”
BackgroundReactive oxygen metabolites, antioxidants and head and neck cancer
Seidman, M. D., Quirk, W. S., & Shirwany, N. A. (1999) · Head & Neck · doi:10.1002/(sici)1097-0347(199908)21:5 · Cited by 35
Ke, B., Shen, X., Lassman, C., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000062861.80771.d5 · Cited by 35
Multiple Organ Failure in Septic Shock
THUS, L. G., Groeneveld, A. B. J., & Hack, C. E. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80186-0_10 · Cited by 34
Tamura, T., Kondo, T., Pak, S., et al. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2011.12.010 · Cited by 34
Sutureless anastomoses using magnetic rings in canine liver transplantation model
Liu, S., Peng, L., Cui, X., et al. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.07.025 · Cited by 34
Zhang, L., Wang, X., Chen, S., Wang, S., Tu, Z., Zhang, G., Zhu, H., Li, X., Xiong, J., & Liu, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113697 · Cited by 33
“Lipopolysaccharide (LPS), a potent endotoxin, plays a critical role in many liver diseases such as alcoholic steatohepatitis [3], nonalcoholic steatohepatitis [4], non-alcoholic fatty liver disease (NAFLD) [4], liver cirrhosis [5] and ischemic liver injury [6].”
BackgroundUrakami, H., Abe, Y., & Grisham, M. B. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04640.x · Cited by 35
Ito, Y., Katagiri, H., Ishii, K., et al. (2003) · European Surgical Research · doi:10.1159/000072174 · Cited by 34
“indicating that the different effects of the selective COX-2 inhibitor on I/R injury might result from differences in tissue specificity.In addition, the current study showed that a selective COX-1 inhibitor, SC-560, decreased ALT levels and the number of leukocytes adhering to the hepatic microvessels after I/R, but…”
BackgroundMitsuoka, H., Suzuki, S., Sakaguchi, T., et al. (1999) · Transplantation · doi:10.1097/00007890-199902270-00004 · Cited by 34
TRANSHEPATIC NEUTROPHIL AND MONOCYTE ACTIVATION DURING CLINICAL LIVER TRANSPLANTATION1
Pesonen, E., qckerstedt, K. H., qkisalo, H. M., et al. (2000) · Transplantation · doi:10.1097/00007890-200004150-00042 · Cited by 34
Metadata
- Authors
- Colletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Strieter, R. M., & Campbell, D. A.
- Affiliations
- University of Michigan (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1990-06-01
- Volume
- 85
- Issue
- 6
- Pages
- 1936-1943
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC296661
- OpenAlex
- W2099883737
- Semantic Scholar
- ef00ab3fc75d2591f58ef3691dd24619b03cf25e
- Cited by
- 817
- References
- 43
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 10 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 16 · 2017: 12 · 2016: 6 · 2015: 15 · 2014: 12 · 2013: 20 · 2012: 24
- FWCI
- 40.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl031237-32)
- National Heart, Lung, and Blood Institute (HL-35276, HL31237, HL 31963, P01HL031963)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- TNF-α, hepatic ischemia-reperfusion injury, cytokines, pulmonary edema, intra-alveolar hemorrhage, neutrophil infiltration, myeloperoxidase, liver injury, systemic inflammatory response, endotoxin
- MeSH terms
- Alanine Transaminase, Animals, Hemodynamics, Ischemia, Liver, Liver Diseases, Lung, Peroxidase, Neutrophils, Time Factors, Tumor Necrosis Factor-alpha, Reperfusion Injury, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
